Eric Ducasse

Eric Ducasse

Auto-generated profile, based on publicly available information

Eric Ducasse

Unit of Vascular Surgery, Université de Bordeaux, CHU de Bordeaux, Bordeaux, France

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2018 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
MNMathilde Nativel
Mathilde Nativel
LPLouis Potier
Louis Potier
LALaure Alexandre
Laure Alexandre
LBLaurence Baillet-Blanco
Laurence Baillet-Blanco
EDEric Ducasse
Eric Ducasse
MKMohammedi Kamel
Mohammedi Kamel
Lower-extremity arterial disease (LEAD) is a major endemic disease with an alarming increased prevalence worldwide. It is a common and severe condition with excess risk of major cardiovascular events and death. It also leads to a high rate of lower-limb adverse events and non-traumatic amputation. The American Diabetes Association recommends a widespread medical history and clinical examination to screen for LEAD. The ankle brachial index (ABI) is the first non-invasive tool recommended to diagnose LEAD although its variable performance in patients with diabetes. The performance of ABI is particularly affected by the presence of peripheral neuropathy, medial arterial calcification, and incompressible arteries. There is no strong evidence today to support an alternative test for LEAD diagnosis in these conditions. The management of LEAD requires a strict control of cardiovascular risk factors including diabetes, hypertension, and dyslipidaemia. The benefit of intensive versus standard glucose control on the risk of LEAD has not been clearly established. Antihypertensive, lipid-lowering, and antiplatelet agents are obviously worthfull to reduce major cardiovascular adverse events, but few randomised controlled trials (RCTs) have evaluated the benefits of these treatments in terms of LEAD and its related adverse events. Smoking cessation, physical activity, supervised walking rehabilitation and healthy diet are also crucial in LEAD management. Several advances have been achieved in endovascular and surgical revascularization procedures, with obvious improvement in LEAD management. The revascularization strategy should take into account several factors including anatomical localizations of lesions, medical history of each patients and operator experience. Further studies, especially RCTs, are needed to evaluate the interest of different therapeutic strategies on the occurrence and progression of LEAD and its related adverse events in patients with diabetes.

1 September 2019 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
CCCaroline Caradu
Caroline Caradu
ELEmilie Lakhlifi
Emilie Lakhlifi
ECElda Chiara Colacchio
Elda Chiara Colacchio
DMDominique Midy
Dominique Midy
XBXavier Bérard
Xavier Bérard
EDEric Ducasse
Eric Ducasse

1 July 2021 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
CCCaroline Caradu
Caroline Caradu
BSBenedetta Spampinato
Benedetta Spampinato
AVAna Maria Vrancianu
Ana Maria Vrancianu
XBXavier Bérard
Xavier Bérard
EDEric Ducasse
Eric Ducasse

23 May 2022 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
CCCaroline Caradu
Caroline Caradu
APAnna Louise Pouncey
Anna Louise Pouncey
ELEmilie Lakhlifi
Emilie Lakhlifi
CBCéline Brunet
Céline Brunet
XBXavier Bérard
Xavier Bérard
EDEric Ducasse
Eric Ducasse

1 February 2017 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
PDF file
CCCaroline Caradu
Caroline Caradu
JMJulien Morin
Julien Morin
MPMathieu Poirier
Mathieu Poirier
DMDominique Midy
Dominique Midy
EDEric Ducasse
Eric Ducasse

1 August 2017 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
CCCaroline Caradu
Caroline Caradu
XBXavier Bérard
Xavier Bérard
DMDominique Midy
Dominique Midy
EDEric Ducasse
Eric Ducasse